Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000025701 http://scihub22266oqcxt.onion/10.1097/MD.0000000000025701 33950951!8104252!33950951     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33950951&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Medicine+(Baltimore) 2021 ; 100 (18): e25701 Nephropedia Template TP {{tp|p=33950951|t=2021. A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone |pdf=|usr=}}{{33950951}} gab.com Text A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=33950951 #FOAvip RATIONALE: Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation. PATIENT CONCERNS: The patient presented with respiratory distress, fever and chills and was diagnosed with COVID-19 pneumonia. His past medical history includes seropositive generalized MG diagnosed in 2019, hypertension, atrial fibrillation and congestive heart failure with reduced ejection failure. DIAGNOSES: Refractory seropositive generalized MG having COVID-19 pneumonia and respiratory failure (needing mechanical ventilation) with sepsis. INTERVENTION: Use of intravenous remdesivir and dexamethasone and patient's myasthenic exacerbation (due to COVID-19 and its complications) was successfully treated with plasmapheresis. OUTCOMES: Patient was successfully weaned off ventilator to trach collar and was discharged to inpatient rehabiliation. He was followed up 1 month post hospital discharge and was on trach collar. LESSONS: This case report illustrates early use of the combination therapy might be beneficial in refractory myasthenia gravis cases even with chronic immunosuppression and severe COVID-19 infection. Twit Text FOAVip A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=33950951 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33950951 #FOAvip English Wikipedia <ref>{{Cite pmid|33950951}}</ref> A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone #MMPMID33950951 Bhagavan SM; Ramaswamy SB; Govindarajan R Medicine (Baltimore) 2021[May]; 100 (18): e25701 PMID33950951show ga RATIONALE: Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation. PATIENT CONCERNS: The patient presented with respiratory distress, fever and chills and was diagnosed with COVID-19 pneumonia. His past medical history includes seropositive generalized MG diagnosed in 2019, hypertension, atrial fibrillation and congestive heart failure with reduced ejection failure. DIAGNOSES: Refractory seropositive generalized MG having COVID-19 pneumonia and respiratory failure (needing mechanical ventilation) with sepsis. INTERVENTION: Use of intravenous remdesivir and dexamethasone and patient's myasthenic exacerbation (due to COVID-19 and its complications) was successfully treated with plasmapheresis. OUTCOMES: Patient was successfully weaned off ventilator to trach collar and was discharged to inpatient rehabiliation. He was followed up 1 month post hospital discharge and was on trach collar. LESSONS: This case report illustrates early use of the combination therapy might be beneficial in refractory myasthenia gravis cases even with chronic immunosuppression and severe COVID-19 infection. |*COVID-19 Drug Treatment[MESH] |Adenosine Monophosphate/*analogs & derivatives/therapeutic use[MESH] |Aged[MESH] |Alanine/*analogs & derivatives/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Dexamethasone/*therapeutic use[MESH] |Drug Therapy, Combination[MESH] |Glucocorticoids/*therapeutic use[MESH] |Humans[MESH] |Male[MESH] |Myasthenia Gravis/*complications[MESH] |Plasmapheresis[MESH] |Pneumonia, Viral/*drug therapy[MESH]A case report of COVID-19 in refractory myasthenia: Outcome with remde(epmc).pdf DeepDyve Pubget Overpricing